L. Zhao

Statistical controversies in clinical research: building the bridge to phase II—efficacy estimation in dose-expansion cohorts

T. Braun, K. Griffith, P. Boonstra, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase III trial of gemcitabine plus docetaxel (GD) compared to capecitabine plus docetaxel (CD) with planned crossover to the alternate single agent in metastatic breast cancer (MBC).

A. Seidman, A. Brufsky, L. Schwartzberg, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined Cytotoxic and Immune Therapy for Primary Adult High-Grade Glioma

T. Lawrence, L. Junck, D. Orringer, 2022, medRxiv.

Individualized treatment of NSCLC: from research to clinical practice.

W. Li, L. Zhao, X. Xi, 2013, Neoplasma.

Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer.

C. Obasaju, C. Russell, L. Hart, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer.

C. Obasaju, A. Seidman, M. Orlando, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.